ResearcherBeckman Research InstituteActive in the last 2 years
Lara C. Avsharian
Matched on ORCID iD 0009-0005-7287-8650; OpenAlex author ID A5006252364. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 2
2024: 1 paper · 2025: none · 2026: 2 papers
Papers 3
- Dual inhibition of CSF-1R and IDO modulates the fibrotic and immunosuppressive tumor microenvironment in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fimmu.2026.1792483↗
- Precision Targeting of Heparan Sulfate Proteoglycans Broadly Dysregulates Survival Signaling and Metabolic Adaptation in Pancreatic Cancer Co-author DOI 10.64898/2026.10.01.756059↗
- Tumor-Colonizing E. coli Expressing Both Collagenase and Hyaluronidase Enhances Therapeutic Efficacy of Gemcitabine in Pancreatic Cancer Models. Co-author DOI 10.3390/biom14111458↗
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Nancy D. Ebelt · 3 shared papers, 2024–2026 · strength 0.89
- Paper Dual inhibition of CSF-1R and IDO modulates the fibrotic and immunosuppressive tumor microenvironment in pancreatic duc… DOI 10.3389/fimmu.2026.1792483↗
- Paper Precision Targeting of Heparan Sulfate Proteoglycans Broadly Dysregulates Survival Signaling and Metabolic Adaptation i… DOI 10.64898/2026.10.01.756059↗
- Paper Tumor-Colonizing E. coli Expressing Both Collagenase and Hyaluronidase Enhances Therapeutic Efficacy of Gemcitabine in … DOI 10.3390/biom14111458↗
- Edwin Ramos Manuel · 3 shared papers, 2024–2026 · strength 0.89
- Paper Dual inhibition of CSF-1R and IDO modulates the fibrotic and immunosuppressive tumor microenvironment in pancreatic duc… DOI 10.3389/fimmu.2026.1792483↗
- Paper Precision Targeting of Heparan Sulfate Proteoglycans Broadly Dysregulates Survival Signaling and Metabolic Adaptation i… DOI 10.64898/2026.10.01.756059↗
- Paper Tumor-Colonizing E. coli Expressing Both Collagenase and Hyaluronidase Enhances Therapeutic Efficacy of Gemcitabine in … DOI 10.3390/biom14111458↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.